State tech hub funding and an expanded partnership with Ember Recreational Vehicles fuel investor optimism in the battery manufacturer.
First patients implanted with the novel neurostimulator marks a key step in challenging market leader Inspire Medical after recent FDA approval.
The designation for ALTO-101 targets cognitive impairment, a debilitating condition with no currently approved treatments, signaling a major regulatory milestone.
A potential leadership reshuffle at the tech giant reportedly positions hardware engineering chief John Ternus to eventually succeed Tim Cook.
Predictive Discovery and Robex Resources merge, creating a mid-tier producer targeting over 400,000 ounces of gold annually.
Conditional approval for Dectomax-CA1 addresses a significant threat to the U.S. livestock industry, boosting company shares.
The pharmaceutical giant is now considered one of Morningstar's highest-conviction undervalued stocks, citing a robust pipeline and strategic acquisitions.
Strategic acquisition aims to bolster Firefly's national security and defense capabilities, expanding its space and defense mission services.